| Literature DB >> 28990913 |
Julie Thwing1, Erin Eckert2, Demba Anta Dione3, Roger Tine4, Adama Faye4, Yazoume Yé5, Medoune Ndiop6, Moustapha Cisse6, Jacques Andre Ndione7, Mame Birame Diouf8,2, Mady Ba6.
Abstract
Malaria is endemic in Senegal. The national malaria control strategy focuses on achieving universal coverage for major interventions, with a goal of reaching preelimination status by 2018. Senegal began distribution of insecticide-treated nets (ITNs) and introduced artemisinin-based combination therapy in 2006, then introduced rapid diagnostic tests in 2007. We evaluated the impact of these efforts using a plausibility design based on malaria's contribution to all-cause under-five mortality (ACCM) and considering other contextual factors which may influence ACCM. Between 2005 and 2010, household ownership of ITNs increased from 20% to 63%, and the proportion of people sleeping under an ITN the night prior to the survey increased from 6% to 29%. Malaria parasite prevalence declined from 6% to 3% from 2008 to 2010 among children under five. Some nonmalaria indicators of child health improved, for example, increase of complete vaccination coverage from 58% to 64%; however, nutritional indicators deteriorated, with an increase in stunting from 16% to 26%. Although economic indicators improved, environmental conditions favored an increase in malaria transmission. ACCM decreased 40% between 2005 and 2010, from 121 (95% confidence interval [CI] 113-129) to 72 (95% CI 66-77) per 1,000, and declines were greater among age groups, epidemiologic zones, and wealth quintiles most at risk for malaria. After considering coverage of malaria interventions, trends in malaria morbidity, effects of contextual factors, and trends in ACCM, it is plausible that malaria control interventions contributed to a reduction in malaria mortality and to the impressive gains in child survival in Senegal.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28990913 PMCID: PMC5619933 DOI: 10.4269/ajtmh.16-0953
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Epidemiologic stratification by parasite prevalence, Senegal 2009.
ITNs, RDTs, ACTs distributed annually in Senegal, 2005–2010
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|
| ITNs | 599,689 | 849,888 | 1,076,141 | 1,586,522 | 2,532,018 | 1,258,663 |
| RDTs | 0 | 148,000 | 374,225 | 625,775 | 1,041,925 | 1,252,900 |
| ACTs | 0 | 2,281,609 | 990,141 | 743,611 | 704,367 | 961,884 |
Source: NMCP Senegal. ACT = artemisinin-based combination therapy dose; ITN = insecticide-treated net; RDT = rapid diagnostic test kit.
This figure represents RDTs being piloted in Senegal prior to the official policy regarding their use being implemented in 2007.
Figure 2.Financial contributions to malaria control in CFA, Senegal 2005–2010. (Source: Senegal National Strategic Framework for Malaria, 2014–2018).
Figure 3.(A) Use of insecticide-treated nets (ITNs) by children under-five by wealth quintile in Senegal, 2005–2010. (B) Use of ITNs by children under-five by epidemiological zone in Senegal, 2005–2010.
Household ownership of, population sleeping under, and population access to ITNs by the general population (all ages) in Senegal, 2005–2010
| Survey | % Of HH with at least one ITN | % Of population sleeping under an ITN the previous night | % Of population with access to an ITN in HH | Ratio use: access |
|---|---|---|---|---|
| DHS 2005 | 20.3 | 5.8 | 9.8 | 0.61 |
| MIS 2006 | 36.6 | 12.2 | 17.5 | 0.69 |
| MIS 2008 | 60.4 | 22.9 | 34.9 | 0.66 |
| DHS 2010 | 62.9 | 28.9 | 38.1 | 0.76 |
ITN = insecticide-treated net; IMS = Malaria Indicator Surveys; HH = household.
Proportion of the population who could have slept under an ITN the night before the survey, in households with nets for every 2 people. (http://www.rollbackmalaria.org/files/files/resources/tool_HouseholdSurveyIndicatorsForMalariaControl.pdf).
Proportion of children under five years with fever during the previous 2 weeks who received a finger or heel stick blood test at any point
| Characteristics | MIS 2008 | DHS 2010 | Variation (95% CI) | |||
|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | |||||
| Total | 4.9 (4.0–5.9) | 4,123 | 9.7 (8.0–11.8) | 2,463 | 4.8 (3.4–6.1) | 0.001 |
| Epidemiologic zone | ||||||
| Dakar | 3.7 (2.3–6.0) | 1,116 | 12.0 (7.8–17.9) | 800 | 8.3 (5.8–10.8) | 0.001 |
| North | 4.1 (3.3–5.1) | 1,613 | 7.4 (5.7–9.0) | 965 | 3.3 (1.4–5.2) | 0.001 |
| Center | 7.9 (5.7–10.1) | 577 | 9.1 (6.1–12.1) | 353 | 1.2 (–2.5;4.9) | 0.26 |
| South | 5.7 (4.1–7.2) | 817 | 11.6 (8.2–14.9) | 344 | 5.9 (2.2–9.6) | 0.001 |
| Socio–economic quintile | ||||||
| Poorest | 5.0 (3.7–6.7) | 901 | 8.0 (5.7–11.0) | 490 | 3.0 (0.2–5.7) | 0.01 |
| Fourth | 5.3 (3.8–7.4) | 808 | 7.7 (5.3–10.9) | 390 | 2.4 (–0.6–5.4) | 0.05 |
| Middle | 5.3 (3.6–7.7) | 796 | 7.8 (5.5–11.0) | 430 | 2.5 (–0.4–5.4) | 0.04 |
| Second | 4.4 (2.8–6.9) | 825 | 9.9 (7.1–13.8) | 626 | 5.5 (2.7–8.2) | 0.001 |
| Least poor | 4.4 (2.5–7.4) | 793 | 14.2 (8.8–22.2) | 528 | 9.8 (6.5–13.1) | 0.001 |
Source: MIS 2008, DHS 2010. N = number of children under five.
Malaria parasite prevalence in children 6–59 months confirmed by microscopy in Senegal, 2008 and 2010
| Characteristics | MIS 2008 | DHS 2010 | Variation (95% CI) | |||
|---|---|---|---|---|---|---|
| % (95% CI) | % (IC 95%) | |||||
| Total | 5.7 (4.4–7.3) | 3,847 | 2.9 (2.1–3.8) | 3,762 | −2.8 (−3.7; −1.8) | 0.001 |
| Age (months) | ||||||
| 6–11 | 2.4 (1.3–4.6) | 340 | 1.9 (0.9–3.8) | 394 | −0.5 (−2.6; 1.6) | 0.32 |
| 12–23 | 3.5 (2.3–5.4) | 863 | 1.4 (0.8–2.6) | 813 | −2.1 (−3.5; −0.6) | 0.002 |
| 24–59 | 6.8 (5.8–7.7) | 2,644 | 3.4 (2.6–4.1) | 2,553 | −3.4 (–4.5; −2.2) | 0.001 |
| Epidemiologic zone | ||||||
| Dakar | 0.8 (0.2–3.2) | 723 | 1.5 (0.4–6.2) | 761 | 0.7 (−0.3; 1.7) | 0.10 |
| North | 2.4 (1.6–3.1) | 1,769 | 1.1 (0.6–1.6) | 1,528 | −1.3 (−2.1; −0.4) | 0.002 |
| Center | 6.9 (5.1–8.6) | 803 | 3.7 (2.4–4.9) | 873 | −3.2 (−5.3; −10.4) | 0.001 |
| South | 20.6 (17.2–23.9) | 552 | 7.7 (0.4–6.2) | 600 | −12.9 (−16.9; −8.9) | 0.001 |
| Wealth quintile | ||||||
| Poorest | 15.8 (12.1–20.4) | 855 | 6.2 (4.2–8.9) | 849 | −9.6 (6.6; 12.5) | 0.001 |
| Fourth | 7.3 (4.7–11.4) | 843 | 2.1 (1.2–3.5) | 817 | −5.0 (−8.7; −1.7) | 0.001 |
| Middle | 1.4 (0.7–2.9) | 825 | 1.6 (0.8–3.3) | 764 | 0.2 (−1.5; 5.5) | 0.86 |
| Second | 0.7 (0.2–2.1) | 709 | 1.6 (0.7–3.7) | 734 | 0.9 (0.5; 1.2) | 0.001 |
| Richest | 0.7 (0.2–3.0) | 615 | 2.3 (0.7–7.3) | 597 | 1.6 (1.3; 4.5) | 0.001 |
Source: DHS 2010, MIS 2008. N = number of children under-five (denominator).
Pearson χ[2] one-sided test.
Laboratory-confirmed* malaria illness episodes incidence per thousand among children under five by epidemiologic zone, in Senegal, 2008–2010
| Epidemiologic zone | 2008 | 2009 | 2010 |
|---|---|---|---|
| Total | 20.7 | 13.4 | 19.8 |
| Dakar | 11.9 | 11.8 | 17.5 |
| North | 10.7 | 6.6 | 11.8 |
| Center | 21.2 | 9.1 | 26.2 |
| South | 62.9 | 40.2 | 37.0 |
Source: NMCP Senegal.
Cases confirmed by RDT in outpatients and microscopy in inpatients, the majority being confirmed by RDT.
Figure 4.Proportional morbidity, proportional mortality, and case fatality rate at health facilities in Senegal, 2001–2009. Proportional morbidity: proportion of all-cause consultations associated with parasitologically confirmed malaria. Proportional mortality: proportion of all hospitalized deaths associated with parasitologically confirmed malaria. Case fatality rate: proportion of hospitalized cases of parasitologically confirmed malaria for whom death is the outcome.
All-cause mortality among children under five per 1,000 live births in Senegal 2005–2010
| Characteristics | DHS 2005 | DHS 2010 | Variation (%) | |||
|---|---|---|---|---|---|---|
| Deaths per 1,000 live births (95% CI) | N | Deaths per 1,000 live births (95% CI) | N | |||
| Total | 121.2 (113.32–129.14) | 19,052 | 71.6 (65.8–77.34) | 19,992 | 40.1 | < 0.001 |
| Age band | ||||||
| 6–11 months | 13.7 (11.9–15.3) | 17,983 | 7.4 (6.2–8.7) | 19,116 | 46.0 | 0.001 |
| 12–23 months | 18.6 (16.7–20.8) | 17,770 | 8.1 (6.4–9.5) | 18,977 | 56.5 | 0.001 |
| 24–59 months | 30.0 (27.5–32.7) | 17,844 | 12.2 (10.7–14.7) | 18,823 | 59.3 | 0.001 |
| Neonatal (0–28 days) | 34.6 (30.4–39.5) | 19,052 | 29.2 (25.48–33.4) | 19,992 | 15.6 | 0.220 |
| Post–neonatal (1–12 months) | 26.4 (23.8–30.8) | 18,295 | 17.5 (15.1–21.0) | 19,357 | 33.7 | 0.001 |
| Infant (0–12 months) | 61.0 (55.4–66.6) | 19,052 | 46.7 (41.9–51.5) | 19,992 | 23.4 | 0.001 |
| Epidemiologic zone | ||||||
| Dakar | 79 (69.9–88.1) | 3,374 | 55.0 (47.7–62.3) | 3,770 | 30.4 | 0.001 |
| North | 100 (93.4–106.5) | 8,021 | 68.0 (62.6–73.4) | 8,442 | 32.0 | 0.001 |
| Center | 123 (113.2–132.7) | 4,338 | 68.0 (60.6–75.3) | 4,500 | 44.7 | 0.001 |
| South | 165 (152.4–177.6) | 3,320 | 96.0 (85.9–52.8) | 3,280 | 41.8 | 0.001 |
| Socioeconomic quintile | ||||||
| Poorest | 162.3 (145.5–178.7) | 4,501 | 96.2 (84.4–100.7) | 4,829 | 40.7 | 0.001 |
| Fourth | 144.0 (129.4–158.3) | 4,328 | 74.2 (63.7–84.7) | 4,448 | 48.4 | 0.001 |
| Middle | 117.2 (99.5–134.5) | 3,963 | 68.7 (56.0–81.3) | 3,868 | 41.3 | 0.001 |
| Second | 89.9 (69.7–109.6) | 3,473 | 64.4 (46.0–82.4) | 3,802 | 28.3 | 0.084 |
| Richest | 68.8 (48.0–91.0) | 2,788 | 43.2 (24.8–61.2) | 3,006 | 37.2 | 0.062 |
Source: DHS 2005, 2010. N = number of children.
Figure 5.Reported deaths due to confirmed malaria and to all causes in public health facilities in Senegal, 2005–2010. Source: NMCP, Senegal.
Evolution of contextual factors related to child health in Senegal 2005–2010
| Factors | DHS 2005 | DHS 2010 | Absolute change % (95% CI) | |||
|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | |||||
| IMCI coverage | ||||||
| Oral rehydration salts for diarrhea (ORS) | 15.1 (13.4–16.6) | 2,168 | 22 (20.3–23.7) | 2,243 | 6.9 (4.6–9.2) | 0.001 |
| Vaccine coverage | ||||||
| BCG | 91.7 (90.5–92.9) | 2,024 | 94.7 (93.7–95.6) | 2,199 | 3.0 (1.4–4.5) | 0.001 |
| DPT3 | 78.3 (75.5–80.1) | 2,024 | 82.6 (81.0–84.2) | 2,199 | 4.3 (1.9–6.7) | 0.001 |
| Polio3 | 72.9 (70.9–74.8) | 2,024 | 72.7 (70.8–74.5) | 2,199 | −0.2 (–2.8;2.5) | 0.442 |
| Measles | 73.9 (71.9–75.8) | 2,024 | 82.1 (80.5–83.7) | 2,199 | 8.2 (5.7–10.7) | 0.001 |
| Complete vaccine coverage | 58.0 (55.9–60.0) | 2,024 | 63.8 (61.7–65.9) | 2,199 | 5.8 (-8.7; −2.8) | 0.001 |
| Micronutrient supplementation | ||||||
| Vitamin A supplementation | 74.4 (73.5–75.2) | 10,077 | 79.3 (78.5–73.5) | 11,633 | 4.9 (3.7–6.0) | 0.001 |
| Nutritional status | ||||||
| Stunting | 16.3 (14.9–17.6) | 2,883 | 26.5 (25.1–27.9) | 3,761 | 10.2 (8.2–12.1) | 0.001 |
| Underweight | 17.3 (15.9–18.7) | 2,883 | 17.7 (16.5–18.9) | 3,761 | 0.4 (−1.4; 2.2) | 0.33 |
| Wasting | 7.6 (6.7–8.4) | 2,883 | 10.1 (9.0–11.2) | 3,761 | −2.5 (–3.8; −1.1) | 0.001 |
| Breastfeeding | ||||||
| Early initiation of breastfeeding | 22.7 (21.6–23.7) | 6,221 | 48.0 (46.5–49.4) | 4,509 | 25.3 (23.5–27.1) | 0.001 |
| Exclusive breastfeeding for < 6 months | 34.1 (32.9–35.2) | 6,221 | 39.0 (37.5–40.4) | 4,509 | 4.9 (3.0–6.7) | 0.001 |
| Other Childhood Illnesses | ||||||
| Prevalence of diarrhea | 22.3 (21.4–23.1) | 9,709 | 20.6 (19.4–21.3) | 10,893 | −1.7 (−2.8; −0.5) | 0.001 |
| Prevalence of ARI | 13.2 (13.5–13.8) | 9,709 | 5.4 (4.9–5.8) | 10,893 | −7.8 (−8.5; −7.0) | 0.001 |
Source: DHS 2005, 2010. ARI = acute respiratory infections.
Figure 6.Weighted Anomaly Standardized Precipitation (WASP) Index for Senegal 1980–2010. Source: IRI, 2014.